Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Counseling program for Black women with HIV and past trauma

Tests a counseling program to help Black women with HIV take their medicines.

Plain-language title generated from the registry record
Registry title: Striving Towards EmPowerment and Medication Adherence R01

Key facts

Where
Miami, United StatesSee the site

Where in United States

  • University of MiamiMiami, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Miami
Trial code
NCT06463886
Record updated
15 October 2026
Original description
This is a study for Black women living with HIV to test a counseling program for Black women living with HIV. This participant may be a good fit if the participant is a Black woman, living with HIV, has a history of trauma, and is currently taking Antiretroviral Therapy (ART) medicinesRead full original descriptionShow less

A Randomized Control Trial of Striving Towards EmPowerment and Medication Adherence (STEP-AD)

This is a study for Black women living with HIV to test a counseling program for Black women living with HIV. This participant may be a good fit if the participant is a Black woman, living with HIV, has a history of trauma, and is currently taking Antiretroviral Therapy (ART) medicines

Inclusion: Black; Living with HIV; Female; Age 18 or older; English speaking; Viral load non-suppression (>200 ml) within the past year OR a detectable HIV viral load (>/= 20 within the past year) OR a lack of HIV viral load measure for 6 consecutive months or more during the past 12 months OR missed HIV care visits greater than 6 months within the past year; History of trauma/abuse; Capable of completing and fully understanding the informed consent process and study procedures.

Exclusion: Unable to completely and fully understand the informed consent process and the study procedures; Significantly interfering mental health symptoms (e.g., active psychosis that is untreated).

ClinicalTrials.gov NCT06463886